🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Efficacy, Safety and Mechanistic Impact of a Heart Failure Guideline-Directed Medical Therapy Clinic Rapid GDMT implementation via an outpatient GDMT clinic was effective, safe, and associated with improvement in key clinical parameters #HeartFailure jacc.org/doi/abs/10.101…

Dr. Christopher Kramer highlights how tirzepatide’s reduction of LV mass and pericardial fat in HFpEF may translate to fewer HF events—pointing to a potential disease-modifying role in obesity-related HFpEF. tinyurl.com/yw8vuke9 #Vumedi #VumediCardio #HFpEF

New CAC staging system brings clarity to statin initiation, LDL targets, and aspirin use—based on guideline-aligned thresholds. Practical, evidence-backed tool for risk-based prevention. Watch the full breakdown via @RightCareInit on #Vumedi tinyurl.com/2b9bn9xe #VumediCardio

Lp(a) is evolving from overlooked biomarker to key therapeutic target. CU Cardiology Dr. Gregory Schwartz explains why it matters, who to screen, and what’s ahead in treatment. Watch the full #Vumedi talk: tinyurl.com/5n6avp4s #VumediCardio

The CLEAR trial found no reduction in CV events with early colchicine post-STEMI/NSTEMI, despite reductions in CRP. Dr. Allen Taylor (MedStar) reviews trial design, limitations, and implications for practice. Watch now on #Vumedi tinyurl.com/mr32sz5k #VumediCardio

No fluoro. Precise lesions. Clean isolation. Eduardo Saad breaks down PFA for AF ablation using ICE + 3D mapping. Watch now on #VuMedi: tinyurl.com/mryj9jr3 #PFA #AFib #VumediCardio

Check out Dean Kereiakes, M.D. recent video on Vumedi!

TAVR access, valve design, imaging & antithrombotics all evolved in 2024. Get the top 10 updates in transcatheter valve therapy from expert faculty. Watch now on #Vumedi: tinyurl.com/yc6aps2z #VumediCardio

Dive into the latest in lipidology at the #NLASessions, May 29–June 1, 2025! Gain insights on dyslipidemia, ASCVD & metabolic health from top experts. CME opportunities available. Hosted by National Lipid Association! Register here: tinyurl.com/ykbn3jtj #Vumedi #VumediCardio

The past year brought major advances in HF treatment: SGLT2i, iron repletion, ATTR therapies, and novel devices are reshaping care. Get the clinical insights every cardiologist should know. Watch now on #Vumedi: tinyurl.com/2uy6k4np #VumediCardio #heartfailure

Check out Revathy Sampath-Kumar MD 's video interview on LVEF Trajectory on Heart Failure Hospitalizations and Mortality after PCI! #Vumedi #Vumedi_Cardio

Honored that Margarida Pujol Lopez shared the CONSYST-CRT trial results with #Vumedi. Check it out! #VumediCardio

Leadless tech, pulsed field ablation, LAA strategies—electrophysiology saw major progress over the past year. Get practical insights for your EP practice in this expert review. Watch on #Vumedi: tinyurl.com/mtjckdsn #VumediCardio #EP

Dr. Renée Bullock-Palmer MD FACC FAHA FASNC FASE FSCCT presents 3 complex nuclear cardiology cases—highlighting coronary steal, multivessel CAD on PET, and TTR amyloid pitfalls—packed with diagnostic insights. Watch now on #Vumedi : tinyurl.com/4vcbv4zm #VumediCardio

2024 brought major advances in cardiomyopathies—aficamten in HCM, new TTR amyloid therapies, gene editing, and fibril-depleters. Dr. Ahmad Masri breaks it all down. Stay ahead! Watch the expert wrap-up on #Vumedi : tinyurl.com/2jd2h6xw #VumediCardio

PFA, leadless dual-chamber pacing, LAAO + AF ablation, and AI in arrhythmia care—Dr. Brian Olshansky unpacks 2024’s biggest EP advances. Don’t miss this forward-looking update. Explore what’s next in electrophysiology on #Vumedi tinyurl.com/2jm34nzk #VumediCardio

Thank you Antonio Frangieh, MD, MPH, FACC, FSCAI for sharing your insights on our platform!

Dr. Philippe Genereux breaks down EARLY TAVR in asymptomatic severe AS, early intervention halved the risk of death, stroke, or CV hospitalization vs surveillance. A pivotal trial with practice-changing potential. Watch the full analysis now on #Vumedi: tinyurl.com/29be2dxt

Dr. Adam Pampori applies the fragility index to FINEARTS-HF revealing a remarkably robust trial. Finerenone shows solid benefit for HFpEF & HFmrEF. What’s next for MRAs? Watch this breakdown for a critical stats-based perspective on #Vumedi :tinyurl.com/sf5keveh #VumediCardio

Dr. Kern reviews key 2024 advances in coronary physiology: FFR pullback gradient, angio-derived FFR, OCT-based flow assessment & MRR. Imaging-guided function is shaping PCI. Catch the insights reshaping diagnostic precision. Watch the recap on #Vumedi tinyurl.com/3j74tmn6